Table 1 IVIG-treated pregnancies and... | American Society of Hematology

Table 1

IVIG-treated pregnancies and therapy effectiveness

AUC	Therapy failure: 21 newborns <50 × 10⁹/L	Therapy success: 38 newborns ≥50 × 10⁹/L	P	Sensitivity, %	Specificity, %	PPV, %	NPV, %
Gestation ≥ 2
<23 IU/mL	5	30	.0001	76.19	78.95	66.67	85.71
≥23 IU/mL	16	8	.0001	76.19	78.95	66.67	85.71
Gestation = 2 (n = 22)
<23 IU/mL	0	15	.0017	100.00	83.36	62.50	100.00
≥23 IU/mL	5	3	.0017	100.00	83.36	62.50	100.00
Gestation > 2 (n = 37)
<23 IU/mL	5	15	.0171	68.75	75.00	68.75	75.00
≥23 IU/mL	11	5	.0171	68.75	75.00	68.75	75.00

AUC	Therapy failure: 21 newborns <50 × 10⁹/L	Therapy success: 38 newborns ≥50 × 10⁹/L	P	Sensitivity, %	Specificity, %	PPV, %	NPV, %
Gestation ≥ 2
<23 IU/mL	5	30	.0001	76.19	78.95	66.67	85.71
≥23 IU/mL	16	8	.0001	76.19	78.95	66.67	85.71
Gestation = 2 (n = 22)
<23 IU/mL	0	15	.0017	100.00	83.36	62.50	100.00
≥23 IU/mL	5	3	.0017	100.00	83.36	62.50	100.00
Gestation > 2 (n = 37)
<23 IU/mL	5	15	.0171	68.75	75.00	68.75	75.00
≥23 IU/mL	11	5	.0171	68.75	75.00	68.75	75.00

P calculated with Fisher’s exact test.

NPV, negative predictive value; PPV, positive predictive value.